BME100 s2015:Group2 9amL2: Difference between revisions
(10 intermediate revisions by 5 users not shown) | |||
Line 13: | Line 13: | ||
{| style="wikitable" width="700px" | {| style="wikitable" width="700px" | ||
|- valign="top" | |- valign="top" | ||
| [[Image: | | [[Image:27b406e2-67c5-46da-9824-5b392bd6d05b.jpg|100px|thumb|Ryan Bridges]] | ||
| [[Image: | | [[Image:IMG8012~2.jpg|100px|thumb|Name: Michael Bejarano]] | ||
| [[Image: | | [[Image:Kokada.jpg|100px|thumb|Name: Fernanda Diva]] | ||
| [[Image: | | [[Image:virginia_fernandez.jpg|100px|thumb|Name: Virginia Fernandez]] | ||
| [[Image: | | [[Image:Morgan_Johnson.jpg|100px|thumb|Morgan Johnson]] | ||
|} | |} | ||
Line 77: | Line 77: | ||
ANOVA was utilized for the human subjects because we were | ANOVA was utilized for the human subjects because we were making comparisons between more than two groups. After using ANOVA, t-tests were used to compare each individual group to each other. | ||
'''Experiment 2''' <br> | '''Experiment 2''' <br> | ||
Line 83: | Line 83: | ||
[[Image:l2_bme_100_ rats_ttest.jpg]] | [[Image:l2_bme_100_ rats_ttest.jpg]] | ||
The T-test performed between the two rat | The T-test performed between the two rat groups. They results didn't yield a P-Value less than 0.05, meaning that there is no significant difference between the two groups. The final analysis of experiment two was that the production of the protein inflammotin within rats via LPS treatment can not be determined to be effective with the data form the experiment. | ||
Line 90: | Line 90: | ||
==Summary/Discussion== | ==Summary/Discussion== | ||
For Experiment 1, on humans, Inflammotin increases significantly with each increased dosage of LPS. This is demonstrated by the calculated t-test value being less than the corrected p-value. The correct p-value was calculated by taking the standard p-value, 0.05, and dividing it by six, the number of comparisons made between dosages. An ANOVA was used to compare the data because there were more than two groups being compared. | For Experiment 1, on humans, Inflammotin increases significantly with each increased dosage of LPS. This is demonstrated by the calculated t-test value being less than the corrected p-value. The correct p-value was calculated by taking the standard p-value, 0.05, and dividing it by six, the number of comparisons made between dosages. An ANOVA was used to compare the data because there were more than two groups being compared. | ||
For Experiment 2, on rats, Inflammotin did not show any significant increase with increased dosages of LPS. The calculated t-test value was greater than the standard p-value | For Experiment 2, on rats, Inflammotin did not show any significant increase with increased dosages of LPS. The calculated t-test value was greater than the standard p-value (which was used because only one comparison was made between two groups). A t-test was used because only one comparison was being made between two groups. | ||
Possibilities of lack of increase of Inflammotin include the LPS not | Possibilities of lack of increase of Inflammotin include the LPS not having the same effective on rats as it does on humans. |
Latest revision as of 19:37, 3 February 2015
BME 100 Spring 2015 | Home People Lab Write-Up 1 | Lab Write-Up 2 | Lab Write-Up 3 Lab Write-Up 4 | Lab Write-Up 5 | Lab Write-Up 6 Course Logistics For Instructors Photos Wiki Editing Help | |||||
OUR TEAMLAB 2 WRITE-UPDescriptive StatisticsExperiment 1 (Humans) Experiment 2 (Rats)
ResultsExperiment 1 (Humans)
AnalysisExperiment 1
Experiment 2 The T-test performed between the two rat groups. They results didn't yield a P-Value less than 0.05, meaning that there is no significant difference between the two groups. The final analysis of experiment two was that the production of the protein inflammotin within rats via LPS treatment can not be determined to be effective with the data form the experiment.
Summary/DiscussionFor Experiment 1, on humans, Inflammotin increases significantly with each increased dosage of LPS. This is demonstrated by the calculated t-test value being less than the corrected p-value. The correct p-value was calculated by taking the standard p-value, 0.05, and dividing it by six, the number of comparisons made between dosages. An ANOVA was used to compare the data because there were more than two groups being compared. For Experiment 2, on rats, Inflammotin did not show any significant increase with increased dosages of LPS. The calculated t-test value was greater than the standard p-value (which was used because only one comparison was made between two groups). A t-test was used because only one comparison was being made between two groups. Possibilities of lack of increase of Inflammotin include the LPS not having the same effective on rats as it does on humans. |